Vascular reactivity and atheromatous plaques in post-menopausal women on tibolone treatment: Open prospective study with Doppler ultrasonography in internal carotid artery

Maturitas

Volumn 50, Issue 4, 2005, Pages 259-265

  Castelo Branco, Camil ^a   García Fantini, Matías ^b   Haya, Javier ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Hospital de Monforte de Lemos   (Spain)

^c HOSPITAL UNIVERSITARIO SANTA CRISTINA   (Spain)

Author keywords

Menopause; Plaque; Tibolone

Indexed keywords

TIBOLONE;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BLOOD FLOW; BLOOD VESSEL DIAMETER; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; BLOOD VESSEL WALL; BRAIN PERFUSION; COMPARATIVE STUDY; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; FOLLOW UP; HUMAN; INTERNAL CAROTID ARTERY; INTIMA; MENOPAUSAL SYNDROME; MORPHOLOGY; POSTMENOPAUSE; SIDE EFFECT; STENOSIS; VAGINA BLEEDING; VASCULAR RESISTANCE; WEIGHT GAIN;

EID: 14944361041     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.04.005     Document Type: Article

References (30)

1. Eaker E., Chesebro J., Sacks F., Wenger N., Winton M. Cardio-vascular disease in women. Circulation. 88:1993;1999-2001
2. Women's health initiative (WHI). Writing group for the WHI investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002;288:321-333.
3. Herrington D.M., Vittinghoff E., Lin F., et al. for the HERS Study Group Statin therapy, cardiovascular events, and total mortality in the heart and estrogen/progestin replacement study (HERS). Circulation. 105:2002;2962-2967
4. Grady D., Herrington D., Bittner V., et al. for the HERS Research Group Cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II). JAMA. 288:2002;49-57
5. Ogita H., Node K., Kitakaze M. The role of estrogen and estrogen-related drugs in cardiovascular diseases. Curr. Drug Metab. 4(6):2003;497-504
6. Rosano G.M., Vitale C., Silvestri A., Fini M. Hormone replacement therapy and cardioprotection: the end of the tale? Ann. N Y Acad. Sci. 997:2003;351-357
7. Castelo-Branco C., Casals E., Figueras F., Sanjuán A., Vicente J.J., Balasch J., Vanrell J.A. Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AI and B. Menopause. 6(2):1999;92-97
8. Ginsburg J, Hardiman P. The peripheral circulation in the menopause. In: Ginsburg J, editor. The circulation in the female. Lancashire: Parthenon; 1989. p. 117-41.
9. Sites C.K. Hormone replacement therapy: cardiovascular benefits for aging women. Coron. Artery Dis. 9:1998;789-793
10. Subbiah M.T.R., Kessel B., Agrawal M., et al. Antioxidant potential of specific estrogens on lipid peroxidation. J. Clin. Endocrinol. Metab. 77:1993;1095-1098
11. Blümel J.E., Castelo-Branco C., González P., Moyano C., Iturriaga M., Videla L., Sanjuán A. Transdermal estrogens do not appear to modify the extension of lesional areas of aortic atherosclerosis in oophorectomized rabbits on a cholesterol-rich diet. Atherosclerosis. 148(2):2000;303-308
12. Gangar K.F., Vyas S., Whitehead M., Crook D., Meire H., Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet. 338(8771):1991;839-842
13. Penotti M., Nencioni T., Gabrielli L., Farina M., Castiglione E., Polvani I. Blood flow variations in internal carotid and middle cerebral arteries induced by menopause hormone replacement therapy. Am. J. Obstet. Gynecol. 169:1993;1226-1232
14. Hillard T., Bourne T., Whitehead M., Crayford T., Collins W., Campbell S. Differential effects of trasdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women. Fert. Sterl. 58:1992;959-963
15. Lukas M., Gleeve T., Bilyan M., Buckett W., Aird I., Drakeley A. The effect of progestagens in the carotid artery pulsatility index in post-menopausal woman on estrogen replacement therapy. Eur. J. Obstet. Gynecol. Reprod. Biol. 56:1998;221-224
16. Blümel J.E., Castelo-Branco C., Leal T., Gallardo L., Saini J., Ferron S., Haya J. Effect of transdermal estrogens on endothelial function in postmenopausal women with coronary disease. Climacteric. 6:2003;38-44
17. Sanjuán A., Castelo-Branco C., Vicente J.J., et al. Cyproterone acetate could counteract the benefits of estradiol valerate in oophorectomized cholesterol-fed rabbits. Menopause. 9:2002;282-287
18. Grodstein F., Stampfer M.J., Colditz G.A., Willett W.C., Manson J.E., Joffe M., Rosner B., et al. Post-menopausal hormone therapy and mortality. N. Engl. J. Med. 336:1997;1769-1775
19. Herrington D.M., Werbel B.L., Riley W.A., Pusser B.E., Morgan T.M. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease. J. Am. Coll. Cardiol. 33:1999;2030-2037
20. Enderle M.D., Sayer R., Balletshofer B., Meisner C., Muck A.O., Haasis R. Acute improvement of peripheral endothelial function in postmenopausal women with coronary artery disease after single oral intake of 17β-estradiol valerate. Experimental and clinical endocrinology & diabetes. 108:2000;382-385
21. Karas R., Patterson B., Mendelsohn M. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation. 89:1994;194-195
22. 2+ in vascular smooth muscle cells. Circ. Res. 76:1995;973-979
23. Weiner C., Lizasoain I. Induction of calcium-dependent nitric oxidosynthases by sex hormones. Proc. Natl. Acad. Sci. U.S.A. 91:1994;5212-5216
24. Henderson B., Paganini-Hill A., Ross R. Estrogen replacement therapy and protection from acute myocardial infarction. Am. J. Obstect. Gynecol. 159:1988;312
25. Wiseman L. Transdermal estradiol/norethisterone: a review of its pharmacological properties and clinical use in postmenopausal women. Drugs Aging. 4:1994;238-256
26. Akkad A., Harsthome T., Bell P., alAzzawi F. Carotid plaque regression on estrogen replacement: a pilo study. Eur. J. Vasc. Endovasc. Surg. 11:1996;347-348
27. Lloyd G, Patel N, McGing E, Cooper A, Kamalvandk, Jackson G. Acute effects of hormone replacement with tibolona on myocardial ischaemia in women with angina. Int J Clin Pract, 1998; 52:155-7.
28. Prelevic G., Beljic T., Grinsburg J. The effect of tibolone on cardiac flow in post-menopausal woman with non-insulin dependent diabetes mellitus. Maturitas. 27:1997;85-90
29. Feher M., Cox A., Levy A., Mayne P., Lant A. Short-term blood pression and metabolic effects of tibolone in post-menopausal woman with non-insulin dependent diabetes. Br. J. Obstet. Gynaecol. 103:1996;281-283
30. Hennerici M., Baezner H., Daffertshofer M. Ultrasound and arterial wall disease. Cerebrovasc. Dis. 17(Suppl 1):2004;19-33